HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Multicenter study of asphyxia neonatorum].

Abstract
Out of 14,673 term infants born at seven neonatal centers in the Barcelona area, 215 newborns were identified as being at risk of developing hypoxic-ischemic encephalopathy. They had shown one or more of the following criteria: fetal pH less than or equal to 7.20, abnormal fetal heart rate patterns, umbilical artery pH less than or equal to 7.20, 5 minute Apgar score less than or equal to 6, or the need for immediate neonatal resuscitation. 135 items were investigated in relation to epidemiological, clinical and laboratory parameters. The incidence of HIE was 6.39% and the mortality was 0.55%. Abnormal neurologic examination was present in 43.7% of 215 term infants at risk, and in 1/10 of them the symptoms were severe. The predictive accuracy of the criteria used in the study was: the most sensitive criteria were the fetal distress and umbilical artery pH, the most specific criteria were the need for immediate neonatal resuscitation and a 5 minute Apgar score less than or equal to 6, and the most efficient criteria were the need for immediate neonatal resuscitation and fetal pH less than or equal to 7.20.
AuthorsM T Esqué, R Baraíbar, J Figueras, E Maurí, M G Moretones, C Padula, J Posa, M A Zuásnabar
JournalAnales espanoles de pediatria (An Esp Pediatr) Vol. 23 Issue 8 Pg. 542-50 (Dec 1985) ISSN: 0302-4342 [Print] Spain
Vernacular TitleEstudio multicéntrico sobre asfixia neonatal.
PMID4096448 (Publication Type: English Abstract, Journal Article)
Topics
  • Apgar Score
  • Asphyxia Neonatorum (diagnosis, epidemiology)
  • Delivery, Obstetric
  • Female
  • Fetal Blood (analysis)
  • Fetal Monitoring
  • Heart Rate
  • Humans
  • Hydrogen-Ion Concentration
  • Hypoxia, Brain (epidemiology)
  • Infant, Newborn
  • Male
  • Prospective Studies
  • Risk
  • Spain

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: